Medical Weight Loss for Cincinnati, Ohio Residents
Cincinnati, Ohio residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Cincinnati through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Cincinnati Residents Choose New Hope Weight Loss
Cincinnati patients choose New Hope Weight Loss because a named physician, Dr. Anjmun Sharma, M.D., oversees every case, pricing is transparent (semaglutide from $166/month, tirzepatide from $233/month · just $7.70/day), and the entire program runs by telehealth from our Costa Mesa, California clinic, which has served over 5,400 patients across Ohio and beyond since 2020.
Cincinnati is served through telehealth from our Costa Mesa, California clinic. The full program runs by secure video, with medication shipped to your Cincinnati address.
Patients across Cincinnati and the surrounding area connect with Dr. Sharma by secure video, wherever they live in Ohio. We care for patients throughout Downtown, Over-the-Rhine, Hyde Park, Clifton, and the greater Cincinnati area. Spanish-speaking Cincinnati patients complete the entire program, intake, consultation, and follow-up, in Spanish with our bilingual team.
Our telehealth model serves Cincinnati and communities across Ohio with the same flat pricing and the same supervising physician. The first step is a $119 physician review; if you are not a candidate you are not charged, and compounded semaglutide starts at $166/month.
GLP-1 Weight Loss Programs Available
Two GLP-1 programs for Cincinnati
Compounded semaglutide starts at $166/month (a 90-day program is $499) and uses the same active ingredient as Wegovy® and Ozempic®, which produced 15-17% average body-weight loss in clinical trials. Compounded tirzepatide starts at $233/month and uses a dual GLP-1/GIP mechanism shown to reach up to 22.5% in trials.
Every plan begins with a $119 physician review. Medication is billed separately, and HSA, FSA, Klarna, and Affirm are all accepted, with no distance surcharge.
How Telehealth Works for Cincinnati
1. Tell us your history through the quiz or intake form. 2. Dr. Sharma confirms your eligibility by secure video, usually within 48 hours. 3. Your compounded medication arrives at your Cincinnati address in cold-pack packaging, with ongoing follow-up from the team, all without leaving home.
Frequently Asked Questions, Cincinnati
How do I get treatment from Cincinnati?
As a Cincinnati, Ohio patient you connect with our Costa Mesa, California clinic by telehealth. Dr. Sharma oversees your plan by secure video and compounded medication ships to your home; eligibility is confirmed during the consultation.
Can I do this without an in-person visit from Cincinnati?
Yes, it is fully telehealth. Your review, prescription, and follow-up are remote, with medication shipped to Cincinnati in cold-pack packaging, no lines and no drive.
How much does it cost for Cincinnati patients?
A $119 physician review, then compounded semaglutide from $166/month or tirzepatide from $233/month (medication separate). HSA, FSA, Klarna, and Affirm are accepted, and there is never a distance surcharge.
What areas of Cincinnati do you serve?
We serve patients from across Cincinnati by telehealth, including Downtown, Over-the-Rhine, Hyde Park, Clifton, and the greater Cincinnati area.
Does the program cost more for Cincinnati patients because of shipping?
No. Pricing is the same nationwide: a $119 physician visit and compounded semaglutide from $166/month, medication billed separately. Cold-pack shipping to Cincinnati is part of the standard process, there is no distance surcharge.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Cincinnati, Ohio by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.